DIAGNOSTIC CAPABILITIES OF [18F]FDG PET/CT IN CASES OF ENDOMETRIAL CANCER: COMPARISON WITH THE RESULTS OF MORPHOLOGICAL EXAMINATION
Open Access
- 9 June 2026
- journal article
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 11 (3) , 227-232
Abstract
Background: endometrial cancer is a common oncological disease of the female reproductive system. Treatment is based on a comprehensive analysis of FIGO staging, degree of differentiation, invasion, and molecular genetic profile of the tumor. Objective: comparative analysis of the metabolic characteristics of the primary tumor based on PET/CT results with [18F]FDG and key prognostic factors of endometrial cancer according to morphological and immunohistochemical studies. Design and methods: A retrospective analysis of 34 patients with morphologically verified endometrial cancer who underwent PET/CT prior to surgical treatment with [18F]FDG. The relationship between the quantitative metabolic characteristics of the primary tumor: the standardized accumulation level (SUVmax), the metabolic volume of the tumor (MTV) and the total glycolytic index (TLG) of the primary tumor with the histological type, degree of differentiation (Grade), the depth of invasion into the myometrium, the presence of lymphovascular invasion and damage to the lymph nodes was investigated. Results: A statistically significant strong positive correlation was found between SUVmax and the degree of neoplasm anaplasia (p=0.68, p0.001). The SUVmax values significantly differed between the Grade groups: Grade 1 – 7.25, Grade 2 – 7.22, and Grade 3 – 12.80 (p0.001). Non-endometrioid histological types and the presence of LVI were also associated with higher values of SUVmax, MTV, and TLG. A moderate positive correlation of SUVmax with the depth of tumor invasion into the myometrium was found (p=0.58, p=0.001). Conclusion: quantitative metabolic characteristics of the primary tumor obtained by PET/CT scans with [18F]FDG can be used for predictive risk stratification as part of a personalized approach to endometrial cancer treatment, as they are closely related to the main histopathological prognostic factors of biological tumor aggressiveness.Keywords
This publication has 14 references indexed in Scilit:
- Cancer of the corpus uteri: A 2025 updateInternational Journal of Gynecology & Obstetrics, 2025
- Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [18F]FDG PET primary tumor radiomicsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2025
- Retrospective analysis of the 18F-FDG PET/CT cutoff value for metabolic parameters was performed as a prediction model to evaluate risk factors for endometrial cancerRadiation Oncology, 2023
- FIGO staging of endometrial cancer: 2023International Journal of Gynecology & Obstetrics, 2023
- Imaging of Endometrial CancerRadiologic Clinics of North America, 2023
- Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer AggressivenessCancers, 2023
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinomaInternational Journal of Gynecological Cancer, 2021
- PET Parameters are Useful in Predicting Endometrial Cancer Risk Classes and PrognosisNuklearmedizin-Nuclear Medicine, 2020
- Current and future approaches to screening for endometrial cancerBest Practice & Research Clinical Obstetrics & Gynaecology, 2020
- High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the LiteratureJournal of Nuclear Medicine, 2016